1. Home
  2. GAB vs NEO Comparison

GAB vs NEO Comparison

Compare GAB & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GAB

Gabelli Equity Trust Inc. (The)

HOLD

Current Price

$5.59

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$17.36

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GAB
NEO
Founded
1986
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Precision Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.1B
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
GAB
NEO
Price
$5.59
$17.36
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$13.38
AVG Volume (30 Days)
593.1K
1.5M
Earning Date
01-01-0001
04-28-2026
Dividend Yield
10.91%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$10.63
Revenue Next Year
N/A
$9.73
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.28
$7.07
52 Week High
$6.37
$19.76

Technical Indicators

Market Signals
Indicator
GAB
NEO
Relative Strength Index (RSI) 40.99 58.79
Support Level $5.46 $15.72
Resistance Level $5.75 $19.76
Average True Range (ATR) 0.05 0.84
MACD -0.01 -0.09
Stochastic Oscillator 0.00 36.90

Price Performance

Historical Comparison
GAB
NEO

About GAB Gabelli Equity Trust Inc. (The)

Gabelli Equity Trust Inc is a non-diversified closed-end management investment company. Its primary investment objective is the long-term growth of capital with income as a secondary objective. The Fund invests at least its assets in equity securities under normal market conditions. Its equity portfolio includes common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities selected by the Investment Adviser. The company invests in various sectors, of which Food & Beverage, Financial Services, Equipment and Supplies, Entertainment, Consumer Products, Health Care, Diversified Industrial, Business Services, Consumer Services and others.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: